Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
DHR Stock Forecast 2025-2026
$209.94
Current Price
$148.45B
Market Cap
Buy 20
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to DHR Price Targets
+47.7%
To High Target of $310.00
+20.3%
To Median Target of $252.50
+4.8%
To Low Target of $220.00
DHR Price Momentum
-2.5%
1 Week Change
+2.4%
1 Month Change
-14.4%
1 Year Change
-8.5%
Year-to-Date Change
-18.7%
From 52W High of $258.23
+22.8%
From 52W Low of $171.00
📊 TOP ANALYST CALLS
Did DHR Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Danaher is one of their latest high-conviction picks.
Latest DHR Stock Price Targets & Analyst Predictions
Based on our analysis of 37 Wall Street analysts, DHR has a bullish consensus with a median price target of $252.50 (ranging from $220.00 to $310.00). The overall analyst rating is Strong Buy (9.2/10). Currently trading at $209.94, the median forecast implies a 20.3% upside. This outlook is supported by 20 Buy, 3 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Paul Knight at Keybanc, projecting a 47.7% upside. Conversely, the most conservative target is provided by Ed Ridley-Day at Rothschild & Co, suggesting a 4.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
DHR Analyst Ratings
20
Buy
3
Hold
0
Sell
DHR Price Target Range
Low
$220.00
Average
$252.50
High
$310.00
Current: $209.94
Latest DHR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for DHR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Oct 23, 2025 | Wells Fargo | Brandon Couillard | Equal-Weight | Maintains | $230.00 |
| Oct 22, 2025 | TD Cowen | Dan Brennan | Buy | Maintains | $260.00 |
| Oct 22, 2025 | Barclays | Luke Sergott | Overweight | Maintains | $250.00 |
| Oct 8, 2025 | Rothschild & Co | Ed Ridley-Day | Neutral | Downgrade | $220.00 |
| Oct 7, 2025 | Evercore ISI Group | Vijay Kumar | Outperform | Maintains | $245.00 |
| Sep 22, 2025 | B of A Securities | Derik De Bruin | Buy | Maintains | $220.00 |
| Jul 23, 2025 | Guggenheim | Subbu Nambi | Buy | Reiterates | $250.00 |
| Jul 23, 2025 | Baird | Catherine Schulte | Outperform | Maintains | $229.00 |
| Jul 23, 2025 | Wells Fargo | Brandon Couillard | Equal-Weight | Maintains | $205.00 |
| Jul 23, 2025 | UBS | Dan Leonard | Buy | Maintains | $225.00 |
| Jul 18, 2025 | Baird | Catherine Schulte | Outperform | Maintains | $226.00 |
| Jul 11, 2025 | Scotiabank | Sung Ji Nam | Sector Outperform | Upgrade | $275.00 |
| Jul 8, 2025 | Evercore ISI Group | Vijay Kumar | Outperform | Maintains | $226.00 |
| Jun 24, 2025 | Barclays | Luke Sergott | Overweight | Maintains | $225.00 |
| Apr 23, 2025 | RBC Capital | Conor McNamara | Outperform | Reiterates | $250.00 |
| Apr 23, 2025 | Guggenheim | Subbu Nambi | Buy | Reiterates | $250.00 |
| Apr 23, 2025 | UBS | Dan Leonard | Buy | Maintains | $240.00 |
| Apr 23, 2025 | Goldman Sachs | Matthew Sykes | Buy | Maintains | $240.00 |
| Apr 23, 2025 | Baird | Catherine Schulte | Outperform | Maintains | $225.00 |
| Apr 22, 2025 | Barclays | Luke Sergott | Overweight | Maintains | $215.00 |
Danaher Corporation (DHR) Competitors
The following stocks are similar to Danaher based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
DHR
Danaher
mkt cap
152.13B
Danaher Corporation (DHR) Financial Data
Danaher Corporation has a market capitalization of $148.45B with a P/E ratio of 43.1x. The company generates $24.27B in trailing twelve-month revenue with a 14.4% profit margin.
Revenue growth is +4.4% quarter-over-quarter, while maintaining an operating margin of +20.8% and return on equity of +6.8%.
Valuation Metrics
Market Cap
$148.45B
Enterprise Value
$164.93B
P/E Ratio
43.1x
PEG Ratio
-1.2x
Price/Sales
6.1x
Growth & Margins
Revenue Growth (YoY)
+4.4%
Gross Margin
+59.3%
Operating Margin
+20.8%
Net Margin
+14.4%
EPS Growth
+11.0%
Financial Health
Cash/Price Ratio
+1.0%
Current Ratio
1.5x
Debt/Equity
35.5x
ROE
+6.8%
ROA
+4.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Danaher Corporation (DHR) Business Model
About Danaher Corporation
What They Do
Develops industrial and healthcare products.
Business Model
Danaher Corporation generates revenue through the design, manufacturing, and sale of innovative products across various sectors, including diagnostics, life sciences, dental, and environmental solutions. Its business model leverages cutting-edge technology and a strong operational culture to enhance product offerings and efficiency, allowing the company to serve a wide range of industries and market needs.
Additional Information
Headquartered in Washington, D.C., Danaher is known for its Danaher Business System (DBS), which focuses on continuous improvement and sustainable innovation. The company's strategic acquisitions and emphasis on research and development have reinforced its leadership position in providing solutions that significantly enhance healthcare, research, and industrial operations.
Company Information
Sector
Healthcare
Industry
Diagnostics & Research
Employees
61,000
CEO
Mr. Rainer M. Blair
Country
United States
IPO Year
1987
Website
www.danaher.comDanaher Corporation (DHR) Latest News & Analysis
Latest News
Quick Summary
Rosen Law Firm is investigating potential fiduciary duty breaches by Danaher Corporation's directors and officers. Shareholders can seek more information on their website.
Why It Matters
Potential breaches of fiduciary duties at Danaher Corporation could lead to legal repercussions, impacting stock value and investor confidence. Monitoring the situation is crucial for shareholders.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Increased investments in a single stock by ultra-rich investors can signal potential market interest and warrant closer observation by other investors.
Why It Matters
Concentration of investments from ultra-rich individuals can signal strong confidence in specific stocks, potentially indicating future price movements and market trends.
Source: 24/7 Wall Street
Market Sentiment:
Positive
Quick Summary
The November 2025 High-Growth Dividend Stock list has a 1.39% yield and 19.88% five-year growth, targeting a 12% annual return with an average 31% discount to fair value.
Why It Matters
The high-growth dividend stocks list indicates potential for solid returns with a significant yield and growth rate, appealing to investors seeking income and capital appreciation.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Rosen Law Firm is investigating potential fiduciary duty breaches by Danaher Corporation's directors and officers. Shareholders can find more details on their website.
Why It Matters
Potential breaches of fiduciary duties at Danaher Corporation could indicate mismanagement or legal issues, impacting stock performance and investor confidence.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Danaher (DHR) is seeing notable trends in international revenue, influencing Wall Street's forecasts and future projections for the stock.
Why It Matters
Danaher's international revenue trends can influence growth projections and stock valuations, affecting investor confidence and market sentiment regarding the company's future performance.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights
15 days ago
Quick Summary
Halper Sadeh LLC is investigating potential breaches of fiduciary duties by Danaher Corporation's officers and directors. Long-term shareholders may pursue corporate governance reforms or other relief.
Why It Matters
Potential breaches of fiduciary duty at Danaher could lead to governance changes, financial restitution, or legal settlements, impacting shareholder value and company stability.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About DHR Stock
What is Danaher Corporation's (DHR) stock forecast for 2026?
Based on our analysis of 37 Wall Street analysts, Danaher Corporation (DHR) has a median price target of $252.50. The highest price target is $310.00 and the lowest is $220.00.
Is DHR stock a good investment in 2026?
According to current analyst ratings, DHR has 20 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $209.94. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for DHR stock?
Wall Street analysts predict DHR stock could reach $252.50 in the next 12 months. This represents a 20.3% increase from the current price of $209.94. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Danaher Corporation's business model?
Danaher Corporation generates revenue through the design, manufacturing, and sale of innovative products across various sectors, including diagnostics, life sciences, dental, and environmental solutions. Its business model leverages cutting-edge technology and a strong operational culture to enhance product offerings and efficiency, allowing the company to serve a wide range of industries and market needs.
What is the highest forecasted price for DHR Danaher Corporation?
The highest price target for DHR is $310.00 from Paul Knight at Keybanc, which represents a 47.7% increase from the current price of $209.94.
What is the lowest forecasted price for DHR Danaher Corporation?
The lowest price target for DHR is $220.00 from Ed Ridley-Day at Rothschild & Co, which represents a 4.8% increase from the current price of $209.94.
What is the overall DHR consensus from analysts for Danaher Corporation?
The overall analyst consensus for DHR is bullish. Out of 37 Wall Street analysts, 20 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $252.50.
How accurate are DHR stock price projections?
Stock price projections, including those for Danaher Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 8, 2025 9:34 AM UTC